Zdrowie i gospodarka · 17/05/1994
Opportunity for a Cooperative Research and Development Agreement (CRADA) for the Development of Adenoviral-Mediated Gene Therapy for the Treatment of Cardiovascular Conditions
The National Heart, Lung and Blood Institute (NHLBI) is seeking partners for a Cooperative Research and Development Agreement (CRADA) to develop adenoviral-mediated gene therapy for treating cardiovascular conditions, specifically restenosis after angioplasty and stimulation of collateral formation in the myocardium.